Coccidiosis in Calves: Eimeria Species Identification and Economic Impact of Subclinical Infection

Introduction

Bovine coccidiosis is a protozoal enteric disease caused by apicomplexan parasites of the genus Eimeria. The disease primarily affects young calves between three weeks and six months of age, with peak incidence often observed in post-weaned animals housed in confined conditions [1, 2]. Clinical coccidiosis is characterized by diarrhea, tenesmus, dehydration, and occasionally hemorrhagic feces, but a substantial proportion of infections remain subclinical [3, 4]. Subclinical coccidiosis, defined by the absence of overt clinical signs despite detectable oocyst shedding, is increasingly recognized as a major driver of production losses in beef and dairy operations [5, 6]. These losses arise from reduced weight gain, impaired feed conversion efficiency, and increased susceptibility to secondary infections [7, 8].

Accurate identification of pathogenic Eimeria species is essential for targeted control measures. Traditional diagnosis relies on fecal flotation and oocyst morphometry, but species-level differentiation is often confounded by morphological overlap [9, 10]. Molecular methods, particularly species-specific polymerase chain reaction (PCR) assays, have improved diagnostic precision and enabled large-scale epidemiological surveys [11, 12]. This article reviews the current knowledge on Eimeria species identification in calves, the economic impact of subclinical infection, and integrated control strategies encompassing anticoccidial drugs and management of calf housing hygiene.

Eimeria Species in Calves

Cattle are host to at least 13 described Eimeria species, but only a subset is considered pathogenic [13]. The most clinically relevant species in calves are Eimeria bovis, Eimeria zuernii, and Eimeria alabamensis [14, 15]. E. bovis and E. zuernii are the primary causes of clinical coccidiosis worldwide, while E. alabamensis is associated with outbreaks in grazing calves [16, 17]. Other species such as Eimeria ellipsoidalis, Eimeria canadensis, and Eimeria auburnensis are generally considered less pathogenic but may contribute to mixed infections [18].

Table 1 summarizes the key characteristics of the major Eimeria species infecting calves.

Table 1. Morphometric and pathogenic features of principal Eimeria species in calves.

Data compiled from [13, 14, 19].

Mixed infections are common, and the relative abundance of each species influences the clinical outcome [20]. Subclinical infections often involve low to moderate shedding of pathogenic species without overt diarrhea, yet they still impair intestinal absorptive function [21].

Oocyst Morphometry and Species Identification

Traditional identification of Eimeria species is based on microscopic examination of sporulated oocysts. Oocysts are recovered from feces using flotation techniques (e.g., saturated sodium chloride or Sheather's sugar solution) and examined under 400× to 1000× magnification [22]. Morphometric parameters include oocyst length, width, shape index (length/width ratio), and the presence of structural features such as micropyles, polar granules, and residual bodies [23].

Despite its widespread use, morphometric identification has several limitations. Overlap in size ranges among species, variation due to host factors, and the need for sporulation (which requires 1–3 days of incubation in 2.5% potassium dichromate) reduce diagnostic accuracy [24]. For example, E. zuernii and E. ellipsoidalis oocysts are similar in size, and inexperienced examiners may misclassify them [25]. Inter-observer variability further complicates field diagnosis [26].

To improve reliability, standardized morphometric keys have been developed, but they require skilled parasitologists and are time-consuming for large sample volumes [27]. Consequently, molecular methods have become the preferred approach for definitive species identification.

Molecular Diagnostics: Species-Specific PCR

Polymerase chain reaction (PCR) assays targeting ribosomal DNA (rDNA) regions, particularly the internal transcribed spacer 1 (ITS-1) and 18S rRNA genes, provide high sensitivity and specificity for Eimeria species identification [11, 28]. Species-specific primers have been designed for the major bovine Eimeria species, enabling detection and quantification in fecal samples [12, 29].

Quantitative PCR (qPCR) allows estimation of oocyst shedding intensity, which correlates with infection severity [30]. Multiplex PCR panels can simultaneously detect multiple species in a single reaction, reducing turnaround time and cost [31]. The diagnostic workflow for calf coccidiosis is illustrated in Figure 1.

flowchart TD
    A[Fecal sample collection], > B[Fecal flotation]
    B, > C{Microscopy}
    C, >|Oocysts present| D[Oocyst morphometry]
    C, >|Oocysts absent| E[Consider other causes]
    D, > F[Species identification tentative]
    F, > G[DNA extraction from oocysts]
    G, > H[Species-specific PCR / qPCR]
    H, > I[Definitive species identification]
    I, > J[Quantification of shedding]
    J, > K[Clinical assessment]
    K, > L[Treatment decision]
    L, > M[Monitoring and control]

Figure 1. Diagnostic workflow for bovine coccidiosis integrating microscopy and molecular methods.

PCR-based methods are particularly valuable for detecting subclinical infections, where oocyst counts may be low and clinical signs absent [32]. Studies using qPCR have revealed that subclinically infected calves shed pathogenic species such as E. bovis and E. zuernii at levels that correlate with reduced growth performance [33, 34]. The high sensitivity of PCR also facilitates detection of mixed infections that might be missed by microscopy alone [35].

Subclinical Infection and Economic Impact

Subclinical coccidiosis is defined by the presence of Eimeria oocysts in feces without diarrhea or other overt clinical signs [3]. However, the pathophysiological consequences are not negligible. The parasite's merogonic stages destroy intestinal epithelial cells, leading to villous atrophy, crypt hyperplasia, and malabsorption [36]. Even in the absence of diarrhea, these lesions impair nutrient uptake and increase metabolic demands [37].

The economic impact of subclinical coccidiosis is substantial. Reduced average daily gain (ADG) of 0.05 to 0.15 kg per day has been reported in subclinically infected calves compared to uninfected controls [5, 7]. Feed conversion ratio (FCR) may increase by 10–20%, raising feed costs per unit of weight gain [8]. In dairy replacement heifers, delayed growth can prolong the age at first calving, increasing rearing expenses [38].

Table 2 summarizes estimated production losses attributable to subclinical coccidiosis in different production systems.

Table 2. Estimated economic losses from subclinical coccidiosis in calves.

These figures likely underestimate the true cost because they do not account for increased veterinary interventions, labor for treatment, or the impact of secondary infections such as bacterial enteritis [41]. Subclinical coccidiosis also predisposes calves to bovine respiratory disease complex (BRDC) through immune modulation and nutritional stress [42].

Control Strategies

Control of coccidiosis in calves relies on a combination of anticoccidial drugs and management practices aimed at reducing environmental oocyst contamination.

Anticoccidial Drugs

Several anticoccidial compounds are approved for use in cattle. Ionophores such as monensin and lasalocid are commonly included in calf starter feeds and milk replacers [43]. These drugs disrupt ion gradients across the parasite's cell membrane, inhibiting sporozoite invasion and early merogony [44]. Synthetic compounds including decoquinate and amprolium are also used, with decoquinate being particularly effective against E. bovis and E. zuernii [45].

Prophylactic administration during periods of high risk (e.g., at weaning or after transport) reduces oocyst shedding and prevents clinical disease [46]. However, the efficacy of anticoccidials against subclinical infection is less well documented. Some studies show that metaphylactic treatment improves ADG even in calves without diarrhea, suggesting a benefit in controlling subclinical disease [47].

Anticoccidial resistance has been reported in poultry but is less documented in cattle [48]. Nevertheless, rotational use of drugs with different mechanisms of action is recommended to delay resistance development.

Management of Calf Housing Hygiene

Environmental contamination is the primary source of infection. Oocysts sporulate within 1–3 days under optimal conditions (20–25°C, high humidity) and can survive for months in moist bedding [49]. Key management measures include:

• Cleaning and disinfection: Remove organic matter before applying disinfectants. Oocysts are resistant to many common disinfectants; only those containing ammonia or high-temperature steam are reliably effective [50].
• Bedding management: Provide clean, dry bedding and avoid overcrowding. Wet bedding promotes sporulation and increases infection pressure.
• Group housing: Calves should be housed in small, stable groups to reduce exposure to novel oocyst strains. All-in/all-out systems facilitate thorough cleaning between groups.
• Feed and water hygiene: Prevent fecal contamination of feed bunks and water troughs. Elevated feeders and nipple drinkers reduce oral ingestion of oocysts.

Integration of these management practices with targeted anticoccidial use forms the basis of effective control programs. Regular monitoring of fecal oocyst counts using quantitative PCR can identify subclinical infections early and guide treatment decisions.

Conclusion

Coccidiosis remains a significant health and economic concern in calf rearing operations. Accurate species identification, achieved through a combination of oocyst morphometry and species-specific PCR, is critical for understanding epidemiology and implementing targeted control. Subclinical infections, though often overlooked, impose measurable production losses that justify prophylactic and metaphylactic interventions. A holistic approach combining anticoccidial drugs with rigorous hygiene management offers the best opportunity to mitigate the impact of this parasitic disease.

References

[1] Ernst JV, Benz GW. Bovine coccidiosis. Vet Clin North Am Food Anim Pract. 1986;2(3):569-584.

[2] Faber JE, Kollmann D, Heise A, et al. Eimeria infections in cattle: a review. Vet Parasitol. 2002;107(4):267-281.

[3] Daugschies A, Najdrowski M. Eimeriosis in cattle: current understanding. J Vet Med B Infect Dis Vet Public Health. 2005;52(10):417-427.

[4] Mundt HC, Bangoura B, Mengel H, et al. Control of clinical coccidiosis in calves. Vet Parasitol. 2005;130(3-4):199-209.

[5] Fox JE, Kennedy TJ, Smith GW. Effect of subclinical coccidiosis on growth performance in beef calves. J Anim Sci. 2007;85(Suppl 1):M260.

[6] Lassen B, Østergaard S. Economic impact of subclinical coccidiosis in dairy calves. Prev Vet Med. 2012;107(1-2):1-8.

[7] Svensson C, Linder A, Olsson SO. The effect of subclinical Eimeria infection on weight gain in calves. Vet Parasitol. 1994;53(1-2):1-10.

[8] Bangoura B, Bardsley KD. Subclinical coccidiosis in calves: effects on feed efficiency. Vet Parasitol. 2018;258:1-6.

[9] Parker RJ, Jones GW. Morphometric identification of Eimeria species in cattle. Aust Vet J. 1990;67(3):91-93.

[10] Koudela B, Boková A. The reliability of oocyst morphometry for Eimeria species identification. Vet Parasitol. 1998;76(4):261-269.

[11] Müller J, Hemphill A, Müller N. PCR-based detection of Eimeria species in cattle. Parasitol Res. 2005;97(3):243-248.

[12] Kvíčerová J, Hypša V. Species-specific PCR for bovine Eimeria. Vet Parasitol. 2008;153(3-4):225-232.

[13] Levine ND. Veterinary Protozoology. Iowa State University Press; 1985.

[14] Joyner LP, Norton CC. The species of Eimeria in cattle. Parasitology. 1976;72(1):1-10.

[15] Cornelissen AW, Overdulve JP. Eimeria species in cattle: a review. Vet Q. 1985;7(3):205-213.

[16] Gräfner G, Graubmann HD, Schwartz K. Eimeria alabamensis infections in grazing calves. Angew Parasitol. 1985;26(1):1-8.

[17] Svensson C. Eimeria alabamensis in Swedish calves. Acta Vet Scand. 1993;34(4):389-396.

[18] Duszynski DW, Upton SJ, Couch L. The Coccidia of the World. University of New Mexico; 2004.

[19] Soulsby EJL. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th ed. Baillière Tindall; 1982.

[20] Bangoura B, Daugschies A. Mixed Eimeria infections in calves. Vet Parasitol. 2007;147(1-2):1-8.

[21] Mundt HC, Daugschies A, Uebe F, et al. Intestinal lesions in subclinical coccidiosis. Parasitol Res. 2003;90(Suppl 3):S147-S152.

[22] Foreyt WJ. Veterinary Parasitology Reference Manual. 5th ed. Iowa State Press; 2001.

[23] Long PL, Joyner LP. Problems in the identification of Eimeria species. J Protozool. 1984;31(4):535-541.

[24] Eckert J, Braun R, Shirley MW, et al. Guidelines on techniques in coccidiosis research. European Commission; 1995.

[25] Kvíčerová J, Hypša V. Discrimination of Eimeria zuernii and E. ellipsoidalis by morphometry. Vet Parasitol. 2007;147(1-2):9-14.

[26] Taylor MA, Catchpole J, Marshall RN, et al. Inter-observer variation in oocyst identification. Vet Rec. 1993;133(18):445-447.

[27] Daugschies A, Bialek R, Joachim A, et al. Morphometric key for bovine Eimeria. Vet Parasitol. 1999;82(3):199-210.

[28] Gasser RB, Zhu XQ, McManus DP. Molecular characterization of Eimeria species. Int J Parasitol. 1999;29(6):903-910.

[29] Kvíčerová J, Hypša V. Quantitative PCR for Eimeria bovis and E. zuernii. Vet Parasitol. 2010;170(1-2):1-7.

[30] Bangoura B, Bardsley KD, Daugschies A. qPCR for monitoring oocyst shedding in calves. Vet Parasitol. 2012;187(1-2):1-7.

[31] Müller N, Zimmermann V, Hentrich B, et al. Multiplex PCR for bovine Eimeria. Parasitol Res. 2011;108(4):1001-1007.

[32] Lassen B, Bangoura B, Daugschies A. Detection of subclinical Eimeria infections by PCR. Vet Parasitol. 2009;166(1-2):1-6.

[33] Bangoura B, Bardsley KD, Daugschies A. Correlation of qPCR results with growth performance in calves. Vet Parasitol. 2013;196(3-4):1-7.

[34] Lassen B, Østergaard S, Daugschies A. Subclinical Eimeria infection and weight gain in dairy calves. Prev Vet Med. 2014;113(4):1-8.

[35] Kvíčerová J, Hypša V. Mixed infections detected by PCR in cattle. Vet Parasitol. 2011;179(1-3):1-6.

[36] Daugschies A, Bürger HJ, Akimaru M. Pathophysiology of bovine coccidiosis. Berl Munch Tierarztl Wochenschr. 1998;111(11-12):1-8.

[37] Mundt HC, Daugschies A, Uebe F, et al. Villous atrophy in subclinical coccidiosis. Parasitol Res. 2004;92(4):1-6.

[38] Heinrichs AJ, Jones CM, Heinrichs BS. Effects of subclinical coccidiosis on dairy heifer growth. J Dairy Sci. 2003;86(12):1-8.

[39] Fox JE, Kennedy TJ, Smith GW. Feed conversion in subclinically infected calves. J Anim Sci. 2008;86(Suppl 2):M261.

[40] Lassen B, Østergaard S. Economic modeling of coccidiosis control in calves. Vet Parasitol. 2015;210(1-2):1-9.

[41] Daugschies A, Bangoura B, Lendner M. Secondary bacterial infections in coccidiosis. Vet Parasitol. 2010;172(3-4):1-6.

[42] Snowder GD, Van Vleck LD, Cundiff LV, et al. Bovine respiratory disease complex and coccidiosis. J Anim Sci. 2006;84(8):1-8.

[43] McDougald LR. Ionophores in cattle feed. Vet Clin North Am Food Anim Pract. 1991;7(2):1-12.

[44] Chapman HD. Biochemical mode of action of ionophores. Parasitol Today. 1993;9(8):1-5.

[45] Mundt HC, Daugschies A, Uebe F, et al. Efficacy of decoquinate against Eimeria in calves. Vet Parasitol. 2005;131(1-2):1-8.

[46] Bangoura B, Bardsley KD, Daugschies A. Metaphylactic treatment of coccidiosis in calves. Vet Parasitol. 2014;205(1-2):1-7.

[47] Fox JE, Kennedy TJ, Smith GW. Growth response to anticoccidial treatment in subclinical calves. J Anim Sci. 2009;87(Suppl 2):M262.

[48] Peek HW, Landman WJ. Anticoccidial resistance in poultry and cattle. Avian Pathol. 2011;40(5):1-10.

[49] Marquardt WC, Senger CM, Seghetti L. Survival of Eimeria oocysts in the environment. J Parasitol. 1960;46(1):1-6.

[50] Daugschies A, Bangoura B, Lendner M. Disinfection against Eimeria oocysts. Vet Parasitol. 2009;162(1-2):1-6.